Literature DB >> 9379202

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.

G Brix1, J Zaers, L E Adam, M E Bellemann, H Ostertag, H Trojan, U Haberkorn, J Doll, F Oberdorfer, W J Lorenz.   

Abstract

UNLABELLED: This study evaluates the performance of the newly developed high-resolution whole-body PET scanner ECAT EXACT HR+.
METHODS: The scanner consists of four rings of 72 bismuth germanate block detectors each, covering an axial field of view of 15.5 cm with a patient port of 56.2 cm. A single block detector is divided into an 8 x 8 matrix, giving a total of 32 rings with 576 detectors each. The dimensions of a single detector element are 4.39 x 4.05 x 30 mm3. The scanner is equipped with extendable tungsten septa for two-dimensional two-dimensional measurements, as well as with three 68Ge line sources for transmission scans and daily quality control. The spatial resolution, scatter fraction, count rate, sensitivity, uniformity and accuracy of the implemented correction algorithms were evaluated after the National Electrical Manufacturers Association protocol using the standard acquisition parameters.
RESULTS: The transaxial resolution in the two-dimensional mode is 4.3 mm (4.4 mm) in the center and increases to 4.7 mm (4.8 mm) tangential and to 8.3 mm (8.0 mm) radial at a distance of r = 20 cm from the center. The axial slice width measured in the two-dimensional mode varies between 4.2 and 6.6 mm FWHM over the transaxial field of view. In the three-dimensional mode the average axial resolution varies between 4.1 mm FWHM in the center and 7.8 mm at r = 20 cm. The scatter fraction is 17.1% (32.5%) for a lower energy discriminator level of 350 keV. The maximum true event count rate of 263 (345) kcps was measured at an activity concentration of 142 (26.9) kBq/ml. The total system sensitivity for true events is 5.7 (27.7) cps/Bq/ml. From the uniformity measurements, we obtained a volume variance of 3.9% (5.0%) and a system variance of 1.6% (1.7%). The implemented three-dimensional scatter correction algorithm reveals very favorable properties, whereas the three-dimensional attenuation correction yields slightly inaccurate results in low- and high-density regions.
CONCLUSION: The ECAT EXACT HR+ has an excellent, nearly isotropic spatial resolution, which is advantageous for brain and small animal studies. While the relatively low slice sensitivity may hamper the capability for performing fast dynamic two-dimensional studies, the scanner offers a sufficient sensitivity and count rate capacity for fully three-dimensional whole-body imaging.

Entities:  

Mesh:

Year:  1997        PMID: 9379202

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  102 in total

1.  Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging.

Authors:  A F Chatziioannou; S R Cherry; Y Shao; R W Silverman; K Meadors; T H Farquhar; M Pedarsani; M E Phelps
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

2.  PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction.

Authors:  H G Buchholz; H Herzog; G J Förster; H Reber; O Nickel; F Rösch; P Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-26       Impact factor: 9.236

3.  Positron flight in human tissues and its influence on PET image spatial resolution.

Authors:  Alejandro Sánchez-Crespo; Pedro Andreo; Stig A Larsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-10       Impact factor: 9.236

4.  [Preoperative imaging as the basis for image-guided neurosurgery].

Authors:  D Winkler; G Strauss; S Hesse; A Goldammer; M Hund-Georgiadis; A Richter; O Sabri; T Kahn; J Meixensberger
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

5.  Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.

Authors:  Keisuke Takahata; Hiroshi Ito; Harumasa Takano; Ryosuke Arakawa; Hironobu Fujiwara; Yasuyuki Kimura; Fumitoshi Kodaka; Takeshi Sasaki; Tsuyoshi Nogami; Masayuki Suzuki; Tomohisa Nagashima; Hitoshi Shimada; Motoichiro Kato; Masaru Mimura; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2012-01-12       Impact factor: 4.530

Review 6.  Positron emission tomography imaging in neurological disorders.

Authors:  Marios Politis; Paola Piccini
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

7.  Improved kinetic analysis of dynamic PET data with optimized HYPR-LR.

Authors:  John M Floberg; Charles A Mistretta; Jamey P Weichert; Lance T Hall; James E Holden; Bradley T Christian
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

8.  D₂-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D₂-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection.

Authors:  Mark E Schmidt; Peter de Boer; Randolph Andrews; Martine Neyens; Stefaan Rossenu; Demiana William Falteos; Erik Mannaert
Journal:  Psychopharmacology (Berl)       Date:  2012-07-07       Impact factor: 4.530

9.  Kinetic models for analysing myocardial [(11)C]palmitate data.

Authors:  Hugo W A M de Jong; Luuk J Rijzewijk; Mark Lubberink; Rutger W van der Meer; Hildo J Lamb; Jan W A Smit; Michaëla Diamant; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

10.  Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Authors:  Nanda C Krak; Jacobus J M van der Hoeven; Otto S Hoekstra; Jos W R Twisk; Elsken van der Wall; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.